Paragon Genomics

Headquartered in Fremont, CA, Paragon Genomics is a dynamic and growing company developing and commercializing breakthrough target enrichment solutions for Next-Generation Sequencing (NGS). We are building a team of passionate scientists, engineers and business professionals who thrive in a collaborative entrepreneurial environment. Our patented CleanPlex amplicon sequencing technology solves the urgent throughput and efficiency bottlenecks of targeted sequencing workflow and is applicable to many fast-growing markets in the genomics space. The Company was selected by a distinguished panel into the California Life Science Association F.A.S.T. Program in March 2016 and was accepted into the prestigious Stanford StartX Medicine Accelerator Program...

Ready-to-use ngs panels,next generation sequencing (ngs),targeted sequencing,custom panel design,ngs library preparation,ngs reagents,target enrichment,custom ngs panels,amplicon sequencing,and custom ngs assay design

Paragon genomics operates in the Biotechnology research industry.

Paragon genomics's revenue is 11m - 100m

Paragon genomics has 11 - 50 employees.